Fig. 2From: Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancerROC curve using CETRUS scores to differentiate prostate cancer from benign disease. The AUC for the CETRUS scores was 0.89 (95% CI: 0.85–0.92, p < 0.0001)Back to article page